Original ResearchSeptember 2021
A Multicenter Prospective Cohort Study
Author, Article and Disclosure Information
Visual Abstract. Treating Acute Pain in Sickle Cell Disease in an Infusion Center vs. the ED.

The authors assessed whether care in an infusion center versus an emergency department leads to improved outcomes in uncomplicated vaso-occlusive crises by following adults with sickle cell disease at 4 U.S. sites and evaluating pain outcomes and whether patients were discharged home or hospitalized.

Background:

Patients with sickle cell disease (SCD) have vaso-occlusive crises (VOCs). Infusion centers (ICs) are alternatives to emergency department (ED) care and may improve patient outcomes.

Objective:

To assess whether care in ICs or EDs leads to better outcomes for the treatment of uncomplicated VOCs.

Design:

Prospective cohort. (ClinicalTrials.gov: NCT02411396)

Setting:

4 U.S. sites, with recruitment between April 2015 and December 2016.

Participants:

Adults with SCD living within 60 miles of a study site.

Measurements:

Participants were followed for 18 months after enrollment. Outcomes of interest were time to first dose of parenteral pain medication, whether pain reassessment was completed within 30 minutes after the first dose, and patient disposition on discharge from the acute care visit. Treatment effects for ICs versus EDs were estimated using a time-varying propensity score adjustment.

Results:

Researchers enrolled 483 participants; the 269 who had acute care visits on weekdays are included in this report. With inverse probability of treatment–weighted adjustment, the mean time to first dose was 62 minutes in ICs and 132 minutes in EDs; the difference was 70 minutes (95% CI, 54 to 98 minutes; E-value, 2.8). The probability of pain reassessment within 30 minutes of the first dose of parenteral pain medication was 3.8 times greater (CI, 2.63 to 5.64 times greater; E-value, 4.7) in the IC than the ED. The probability that a participant’s visit would end in admission to the hospital was smaller by a factor of 4 (0.25 [CI, 0.18 to 0.33]) with treatment in an IC versus an ED.

Limitation:

The study was restricted to participants with uncomplicated VOCs.

Conclusion:

In adults with SCD having a VOC, treatment in an IC is associated with substantially better outcomes than treatment in an ED.

Primary Funding Source:

Patient-Centered Outcomes Research Institute.

References

  • 1. Hassell KL Population estimates of sickle cell disease in the U.S. Am J Prev Med2010;38:S512-21. [PMID: 20331952] doi:10.1016/j.amepre.2009.12.022 CrossrefMedlineGoogle Scholar
  • 2. Smith LA Oyeku SO Homer C et alSickle cell disease: a question of equity and quality. Pediatrics2006;117:1763-70. [PMID: 16651336] CrossrefMedlineGoogle Scholar
  • 3. Platt OS Thorington BD Brambilla DJ et alPain in sickle cell disease. Rates and risk factors. N Engl J Med1991;325:11-6. [PMID: 1710777] CrossrefMedlineGoogle Scholar
  • 4. Brousseau DC Owens PL Mosso AL et alAcute care utilization and rehospitalizations for sickle cell disease. JAMA2010;303:1288-94. [PMID: 20371788] doi:10.1001/jama.2010.378 CrossrefMedlineGoogle Scholar
  • 5. Haywood C Jr, Beach MC, Lanzkron S, et al. A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. J Natl Med Assoc2009;101:1022-33. [PMID: 19860302] CrossrefMedlineGoogle Scholar
  • 6. Power-Hays A McGann PT When actions speak louder than words—racism and sickle cell disease. N Engl J Med2020;383:1902-1903. [PMID: 32871062] doi:10.1056/NEJMp2022125 CrossrefMedlineGoogle Scholar
  • 7. Ballas SK Gupta K Adams-Graves P Sickle cell pain: a critical reappraisal. Blood2012;120:3647-56. [PMID: 22923496] doi:10.1182/blood-2012-04-383430 CrossrefMedlineGoogle Scholar
  • 8. Buchanan GR, Yawn BP, Afenyi-Annan AN, et al. Evidence-Based Management of Sickle Cell Disease. National Heart, Lung, and Blood Institute; 2014. Google Scholar
  • 9. Benjamin LJ Swinson GI Nagel RL Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises. Blood2000;95:1130-6. [PMID: 10666181] CrossrefMedlineGoogle Scholar
  • 10. Imbach P Day hospital versus inpatient management: an economic initiative of a pediatric center, examplified on uncomplicated vaso-occlusive crises of children with sickle cell disease. Pediatr Blood Cancer2008;51:317. [PMID: 18383149] doi:10.1002/pbc.21560 CrossrefMedlineGoogle Scholar
  • 11. Raphael JL Kamdar A Wang T et alDay hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease. Pediatr Blood Cancer2008;51:398-401. [PMID: 18300322] doi:10.1002/pbc.21537 CrossrefMedlineGoogle Scholar
  • 12. Adewoye AH Nolan V McMahon L et alEffectiveness of a dedicated day hospital for management of acute sickle cell pain [Letter]. Haematologica2007;92:854-5. [PMID: 17550862] CrossrefMedlineGoogle Scholar
  • 13. Wright J Bareford D Wright C et alDay case management of sickle pain: 3 years experience in a UK sickle cell unit. Br J Haematol2004;126:878-80. [PMID: 15352993] CrossrefMedlineGoogle Scholar
  • 14. Lanzkron S Carroll CP Hill P et alImpact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis. Am J Hematol2015;90:376-80. [PMID: 25639822] doi:10.1002/ajh.23961 CrossrefMedlineGoogle Scholar
  • 15. Bhakta HC Marco CA Pain management: association with patient satisfaction among emergency department patients. J Emerg Med2014;46:456-64. [PMID: 23849365] doi:10.1016/j.jemermed.2013.04.018 CrossrefMedlineGoogle Scholar
  • 16. Li F Zaslavsky AM Landrum MB Propensity score weighting with multilevel data. Stat Med2013;32:3373-87. [PMID: 23526267] doi:10.1002/sim.5786 CrossrefMedlineGoogle Scholar
  • 17. Lumley T. Analysis of complex survey samples. J Stat Softw. 2004;9. doi:10.18637/jss.v009.i08 Google Scholar
  • 18. Lunceford JK Davidian M Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med2004;23:2937-60. [PMID: 15351954] CrossrefMedlineGoogle Scholar
  • 19. Hoffman EB, Sen PK, Weinberg CR. Within-cluster resampling. Biometrika. 2001;88:1121-34. doi:10.1093/biomet/88.4.1121 Google Scholar
  • 20. VanderWeele TJ Ding P Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med2017;167:268-274. [PMID: 28693043] doi:10.7326/M16-2607 LinkGoogle Scholar
  • 21. Mathur MB Ding P Riddell CA et alWeb site and R package for computing E-values. Epidemiology2018;29:e45-e47. [PMID: 29912013] doi:10.1097/EDE.0000000000000864 CrossrefMedlineGoogle Scholar
  • 22. Han J Saraf SL Kavoliunaite L et alProgram expansion of a day hospital dedicated to manage sickle cell pain [Letter]. Am J Hematol2018;93:E20-E21. [PMID: 29023977] doi:10.1002/ajh.24938 CrossrefMedlineGoogle Scholar
  • 23. Tanabe P Silva S Bosworth HB et alA randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD). Am J Hematol2018;93:159-168. [PMID: 29047145] doi:10.1002/ajh.24948 CrossrefMedlineGoogle Scholar
  • 24. Brennan-Cook J Bonnabeau E Harris-Bloom H et alImproving the care of individuals with sickle cell disease in the emergency department using a quality improvement framework: the emergency department sickle cell assessment of needs and strengths (ED-SCANS). Adv Emerg Nurs J2019;41:261-270. [PMID: 31356252] doi:10.1097/TME.0000000000000256 CrossrefMedlineGoogle Scholar
  • 25. Rizk S Axelrod D Riddick-Burden G et alClinical transformation in care for patients with sickle cell disease at an urban academic medical center. Am J Med Qual2020;35:236-241. [PMID: 31496258] doi:10.1177/1062860619873402 CrossrefMedlineGoogle Scholar
  • 26. Evensen CT Treadwell MJ Keller S et alQuality of care in sickle cell disease: cross-sectional study and development of a measure for adults reporting on ambulatory and emergency department care. Medicine (Baltimore)2016;95:e4528. [PMID: 27583862] doi:10.1097/MD.0000000000004528 CrossrefMedlineGoogle Scholar